Reviews for Charles B. Hensley's Cold Wars: The Zicam Story (published April 24, 2025) generally focus on its fast-paced, "unconventional" narrative style and its blend of biotech history with personal drama.

Key Review Themes

• Riveting Business Narrative: Reviewers frequently describe the book as a "rollercoaster ride" that captures the high-stakes world of biotech startups. It is noted for detailing the transition from academia to entrepreneurship, including investor skepticism and corporate conflicts.
• Cinematic Quality: Some readers have highlighted the story's "great movie potential," comparing its energy to a fast-moving thriller.
• Controversial & Edgy Tone: The book is praised for its "humor, chaos, and edgy behavior," offering a raw look at Hensley's life beyond scientific research—including references to a "wild" academic past.
• Insight into Innovation: Feedback emphasizes the "incredible insight" into how Zicam was developed from zinc research and launched despite heavy competition.
• Themes of Resilience: Readers resonate with the central themes of ambition and transformation, following the founders through a path of "buffoonery and eventual triumph". 

Reader Ratings Summary
While specific aggregate star ratings fluctuate, the book has received 5-star feedback from early reviewers who appreciate its unique perspective on the healthcare industry. Critics and readers alike note the "clash of intellect, ambition, and rebellion" as a primary draw.